Injectable HIV Prevention Better Than Pills in Two Trials - Medscape

One trial confirmed the efficacy of CAB LA for transgender women who were also receiving gender-affirming hormone therapy.

MONTREAL Long-acting, injectable cabotegravir (CAB LA) continues to show superiority over oral daily tenofovir diphosphate plus emtricitabine (TDF-FTC) as preexposure prophylaxis (PrEP) for HIV, acco… [+4627 chars]

full article...